Endo Tools Therapeutics receives positive opinion from French High Authority on Health on Forfait Innovation scheme to treat patients with diabetes

Following positive opinion, medical devices company plans to request temporary funding to conduct clinical study of its endomina® device in patients in France with type II diabetes and class I obesity Gosselies, Belgium, June 14, 2022 – Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, the French High […]

Please confirm your location. Content for healthcare professionals only.